Heart Test Laboratories, Inc. financial data

Symbol
HSCS, HSCSW on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
550 Reserve St, Suite 360, Southlake, TX
State of incorporation
TX
Fiscal year end
April 30
Latest financial report
10-Q - Q2 2024 - Sep 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 287 % +117%
Quick Ratio 31.4 % +2.65%
Debt-to-equity 52.5 % -97.9%
Return On Equity -144 % +96.9%
Return On Assets -94.5 % +45.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 911K shares -91.7%
Common Stock, Shares, Outstanding 906K shares -91.5%
Entity Public Float 21.1M USD +17.9%
Common Stock, Value, Issued 907 USD -91.5%
Weighted Average Number of Shares Outstanding, Basic 778K shares +653%
Weighted Average Number of Shares Outstanding, Diluted 778K shares +653%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14.7K USD +654%
Cost of Revenue 4.56K USD +500%
Research and Development Expense 3.54M USD +36.5%
Operating Income (Loss) -7.05M USD -17.2%
Nonoperating Income (Expense) -239K USD -78.1%
Net Income (Loss) Attributable to Parent -7.29M USD -18.6%
Earnings Per Share, Basic -8.41 USD/shares +91%
Earnings Per Share, Diluted -8.41 USD/shares +91%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.34M USD +654%
Accounts Receivable, after Allowance for Credit Loss, Current 14.7K USD
Inventory, Net 643K USD -4.93%
Other Assets, Current 40.4K USD 0%
Assets, Current 6.07M USD +199%
Property, Plant and Equipment, Net 86.1K USD +46%
Operating Lease, Right-of-Use Asset 441K USD -13.6%
Assets 8.19M USD +215%
Accounts Payable, Current 397K USD -12.8%
Accrued Liabilities, Current 331K USD -47.5%
Liabilities, Current 1.35M USD -28.8%
Operating Lease, Liability, Noncurrent 406K USD -20.8%
Liabilities 2.26M USD -27.6%
Retained Earnings (Accumulated Deficit) -69.4M USD -11.7%
Stockholders' Equity Attributable to Parent 5.93M USD
Liabilities and Equity 8.19M USD +215%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.02M USD -43.8%
Net Cash Provided by (Used in) Financing Activities 552K USD +70.1%
Net Cash Provided by (Used in) Investing Activities -833 USD +83%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 906K shares -91.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.47M USD -35.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.34M USD +654%
Deferred Tax Assets, Valuation Allowance 13.6M USD +13.2%
Operating Lease, Liability 512K USD -12.2%
Depreciation 11.9K USD +61.7%
Payments to Acquire Property, Plant, and Equipment 4.91K USD -32.2%
Lessee, Operating Lease, Liability, to be Paid 644K USD
Property, Plant and Equipment, Gross 598K USD +11.1%
Operating Lease, Liability, Current 106K USD +50.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 170K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 166K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 132K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 145K USD
Deferred Tax Assets, Operating Loss Carryforwards 11.7M USD +13.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 174K USD +2.51%
Operating Lease, Payments 13.1K USD 0%
Additional Paid in Capital 75.3M USD +22.3%
Interest Expense 354K USD +45.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%